Back

Lipid lowering treatment for selected patient populations.

2 September 2019 (09:35 - 10:00)
Organised by:
Congress Presentation Part of: 2019 ESC/EAS Guidelines on Dyslipidaemias Drug therapy Open Access ESC Congress 2019

About the speaker

Photo
Professor Francois Mach

University hospitals of Geneva, Geneva (Switzerland)

3 More presentations in this session

Presentation thumbnail
Risk stratification for atherosclerotic cardiovascular disease.
Professor B. Ference (Cambridge, GB)
Slides Video
Presentation thumbnail
Imaging to improve selection of patients for lipid-lowering treatment.
Doctor V. Delgado (Barcelona, ES)
Slides Video
Presentation thumbnail
Formulating appropriate lipid-lowering treatment goals and strategies.
Professor A. Catapano (Milan, IT)
Slides Video

Access the full session

Session thumbnail
2019 ESC/EAS Guidelines on Dyslipidaemias

The Event

Event poster

ESC Congress 2019

2 September 2019 09:35 CET
You may be interested in
thumbnail
Webinar
How to treat patients with borderline dyslipidemia
8 February 2023
thumbnail
Congress Presentation
Target populations and treatment cost for bempedoic acid and PCSK9 inhibitors: a simulation study in a contemporary CAD cohort
27 August 2021
thumbnail
Congress Presentation
A collaborative working project in primary care: optimising lipid lowering therapies for secondary prevention in high risk patients
4 April 2025
thumbnail
Congress Presentation
Sex-related differences regarding results of lipid-lowering therapies, implemented through telematic consultation, after an acute coronary syndrome.
13 April 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources